Alberto Auricchio, MD is Professor of Medical Genetics at “Federico II” University in Naples, and Coordinator of the Molecular Therapy Program at TIGEM in Pozzuoli (NA), Italy. His research is focused on gene therapy of retinal and metabolic diseases using adeno-associated viral vectors. Prof. Auricchio is co-author of more than 140 peer-reviewed publications and inventor of several international patents. He serves as a member of the ESGCT Executive Board and is founder of InnovaVector. Prof. Auricchio has received the Outstanding New Investigator Award of the ASGCT, the International Prize “Arrigo Recordati” and the Consolidator and Advanced Grants from the ER.